Indication
Pachyonychia Congenita
1 clinical trial
1 product
Product
PTX-022Clinical trial
A Multicenter Open-Label Treatment Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia CongenitaStatus: Recruiting, Estimated PCD: 2023-10-01